The HUMMINGBIRD study is testing an investigational vaccine that is designed to prevent coronavirus disease 2019 (COVID-19).
The study vaccine is a protein-based (or traditional) vaccine and is not an mRNA vaccine.
NVX-CoV2373 has been authorized in various countries for adolescents and adults 12 years of age and older.
Now, researchers are evaluating it for children ages 6 months to 2 years.
To be eligible for this study, your child must:
• Be 6 months to 2 years of age
• Not have received a previous vaccine to protect against COVID-19
• Not have received any medications to prevent or treat COVID-19
This is not a complete list of eligibility criteria. The study doctor
will review the full entry criteria for this study with you.
Call (972) 746-2222 Now to Find Out if Your Child Qualifies for this Study.
Leave a message if after or before business hours, and a screener will call you on the next business day.
Site Staff Name:
Jeffrey Adelglass, M.D., F.A.C.S.
Telephone: (972) 746-2222
Fluish.com
Jeffrey Adelglass, M.D., F.A.C.S. | Research Your Health | 6020 West Parker RD STE 305, Plano, Texas 75093, USA
Copyright © 2022 Fluish.com - All Rights Reserved.